Literature DB >> 26039883

Addition of CpG ODN and Poly (I:C) to a standard maturation cocktail generates monocyte-derived dendritic cells and induces a potent Th1 polarization with migratory capacity.

Mei Zhu1, Wei Xu, Hong Su, Qiong Huang, Baolong Wang.   

Abstract

Monocyte-derived dendritic cells (DCs) are used as immunoadjuvant cells in cancer vaccines and have made great progress. However, an optimal DCs subset is vital for this treatment effect, the current 'gold standard' cytokine cocktail DCs have a shortcoming in their cytokines secretion, especially IL-12p70, mainly because of the existence of PGE2. Therefore, it is necessary to find an appropriate DCs-based immunotherapeutic protocol. In this study, we compared a novel 'improved' maturation cytokine cocktail with the current 'gold standard' maturation cytokine cocktail used for generating standard DCs. The 'improved' maturation cytokine cocktail DCs showed a higher levels surface markers expression (CD80, CD83, CD86 and HLA-DR), the chemokine receptors CXCR4 and CCR7 and chemokine CCL19, CCL21 and CXCL21, whereas CCR5 expression was reduced. Most importantly, in contrast to 'gold standard' DCs, which secrete little IL-12p70 and as a result induce mainly Th2 immunity, 'improved' cytokine cocktail DCs secreted higher levels IL-12p70 and also secreted similar concentration IL-10. To removal of PGE2 from the 'improved' DCs did increase the IL-12p70 production. In conclusion, we here present the 'improved' DCs, as an optimal maturation cocktail protocol, can induce high migratory potential, generate immunostimulatory DCs, produce higher levels IL-12p70 with superior capacity to induce Th1 immunity, when compared with the 'gold standard' DCs.

Entities:  

Keywords:  PGE2; RNA electroporation; chemokine; chemokine receptor; cytokine cocktail; dendritic cells; migration; ‘improved’

Mesh:

Substances:

Year:  2015        PMID: 26039883      PMCID: PMC4514291          DOI: 10.1080/21645515.2015.1046659

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  63 in total

1.  A Toll-like receptor recognizes bacterial DNA.

Authors:  H Hemmi; O Takeuchi; T Kawai; T Kaisho; S Sato; H Sanjo; M Matsumoto; K Hoshino; H Wagner; K Takeda; S Akira
Journal:  Nature       Date:  2000-12-07       Impact factor: 49.962

Review 2.  Dendritic cells: specialized and regulated antigen processing machines.

Authors:  I Mellman; R M Steinman
Journal:  Cell       Date:  2001-08-10       Impact factor: 41.582

3.  T cell responses in melanoma patients after vaccination with tumor-mRNA transfected dendritic cells.

Authors:  Jon Amund Kyte; Gunnar Kvalheim; Kari Lislerud; Per thor Straten; Svein Dueland; Steinar Aamdal; Gustav Gaudernack
Journal:  Cancer Immunol Immunother       Date:  2006-09-01       Impact factor: 6.968

4.  A clinical grade cocktail of cytokines and PGE2 results in uniform maturation of human monocyte-derived dendritic cells: implications for immunotherapy.

Authors:  Andrew W Lee; Tuan Truong; Kara Bickham; Jean-Francois Fonteneau; Marie Larsson; Ida Da Silva; Selin Somersan; Elaine K Thomas; Nina Bhardwaj
Journal:  Vaccine       Date:  2002-12-19       Impact factor: 3.641

5.  Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E(2) regulates the migratory capacity of specific DC subsets.

Authors:  Thomas Luft; Michael Jefford; Petra Luetjens; Tracey Toy; Hubertus Hochrein; Kelly-Anne Masterman; Charlie Maliszewski; Ken Shortman; Jonathan Cebon; Eugene Maraskovsky
Journal:  Blood       Date:  2002-08-15       Impact factor: 22.113

6.  Synergistic activation of innate immunity by double-stranded RNA and CpG DNA promotes enhanced antitumor activity.

Authors:  Mark M Whitmore; Michael J DeVeer; Andrea Edling; Rhonda K Oates; Brenna Simons; Daniel Lindner; Bryan R G Williams
Journal:  Cancer Res       Date:  2004-08-15       Impact factor: 12.701

Review 7.  Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters.

Authors:  Lotte Engell-Noerregaard; Troels Holz Hansen; Mads Hald Andersen; Per Thor Straten; Inge Marie Svane
Journal:  Cancer Immunol Immunother       Date:  2008-08-22       Impact factor: 6.968

8.  Effect of ex vivo culture duration on phenotype and cytokine production by mature dendritic cells derived from peripheral blood monocytes.

Authors:  Abdul Tawab; Yong Fan; Elizabeth J Read; Roger J Kurlander
Journal:  Transfusion       Date:  2009-03       Impact factor: 3.157

Review 9.  Current developments in cancer vaccines and cellular immunotherapy.

Authors:  Antoni Ribas; Lisa H Butterfield; John A Glaspy; James S Economou
Journal:  J Clin Oncol       Date:  2003-06-15       Impact factor: 44.544

Review 10.  Role of G protein-coupled receptors in control of dendritic cell migration.

Authors:  Yuan Liu; Guixiu Shi
Journal:  Biomed Res Int       Date:  2014-03-10       Impact factor: 3.411

View more
  4 in total

1.  Repulsive guidance molecule a blockade exerts the immunoregulatory function in DCs stimulated with ABP and LPS.

Authors:  Xuxu Xu; Yan Gao; Zhiyong Zhai; Shuo Zhang; Fengping Shan; Juan Feng
Journal:  Hum Vaccin Immunother       Date:  2016-03-17       Impact factor: 3.452

2.  Distinct roles but cooperative effect of TLR3/9 agonists and PD-1 blockade in converting the immunotolerant microenvironment of irreversible electroporation-ablated tumors.

Authors:  Fatma Babikr; Jiangbo Wan; Aizhang Xu; Zhaojia Wu; Shahid Ahmed; Andrew Freywald; Rajni Chibbar; Yue Wu; Michael Moser; Gary Groot; Wenjun Zhang; Bing Zhang; Jim Xiang
Journal:  Cell Mol Immunol       Date:  2021-11-15       Impact factor: 11.530

3.  Dendritic cells engineered to secrete anti-DcR3 antibody augment cytotoxic T lymphocyte response against pancreatic cancer in vitro.

Authors:  Jiang Chen; Xiao-Zhong Guo; Hong-Yu Li; Jia-Jun Zhao; Wen-Da Xu
Journal:  World J Gastroenterol       Date:  2017-02-07       Impact factor: 5.742

Review 4.  Gene Expression Profiling of Human Monocyte-derived Dendritic Cells - Searching for Molecular Regulators of Tolerogenicity.

Authors:  Katina Schinnerling; Paulina García-González; Juan Carlos Aguillón
Journal:  Front Immunol       Date:  2015-10-19       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.